Safety and Efficacy of Complement Factor H (CFH) Inhibitor GT103 in Advanced Non-Small Cell Lung Cancer (NSCLC): Results of a Phase Ib First in Human Dose Escalation Study.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined